3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 2,443,617 shares, an increase of 345.1% from the May 14th total of 549,065 shares. Based on an average daily volume of 12,127 shares, the days-to-cover ratio is presently 201.5 days.
3SBio Price Performance
Shares of OTCMKTS TRSBF opened at $2.20 on Thursday. 3SBio has a 52-week low of $2.00 and a 52-week high of $4.74. The business’s 50 day moving average is $2.74 and its two-hundred day moving average is $3.03.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
See Also
- Five stocks we like better than 3SBio
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
